The 12th annual World Vaccine Congress Lyon is the vaccine conference addressing all major vaccine markets including Influenza, HPV, Pneumococcal and Meningococcal.

 
 
WHAT TO EXPECT FROM THE CONGRESS
  • Expect to do business with over 250 senior executives over 4 days
     
  • Bring home an extensive list of business leads and close the deal that you have been aiming for
     
  • Find out how your peers and competitors are achieving business success
» download the brochure 
 
Start discussions with future partners
 
 
11 YEARS BUILDING THE VACCINE EVENT THAT YOU CANNOT AFFORD TO MISS
Influenza planning and response
Strategies for continued seasonal, pandemic and universal vaccine innovation and development. Continue market positioning in light of refocused governmental response.
 
Market innovation and exclusivity
Innovative vaccine positioning and label expansion continuing to offer up growing and novel revenue streams and advanced R&D.
 
Emerging market potential
Realising the opportunities from developing regions and their market worth. Position your company strategically for collaborative partnerships.
 
Market M&A, access and entry
Key stage market access planning and global coordination efforts for product launches and market entry opportunities.
 
Advent of externalisation
Evaluate and adapt to emerging search and develop models and align to a paradigm shift to drive the next generation of vaccine pipelines and R&D.
 
 
Formal and informal networking time
 
 
KEY THEMES AT THE EVENT
  • From R&D to S&E; a paradigm shift for vaccine R&D
  • Innovative vaccine differentiation and indication expansion
  • New vaccine franchise evolution
  • Penetrating emerging markets for revenue growth
  • Creative market-access strategies, market innovation and expansion
  • Capturing value and contributing to partnership success
  • Novel vaccine engineering, adjuvant development and antigen delivery advances
  • Accessing innovation: the increasing importance of externalisation
  • Advancing regulatory pathways and bridging the safety divide
 
 
  
A THOUGHT-LEADING SPEAKING FACULTY
DR ROBIN ROBINSON
DR ROBIN ROBINSON
Director, BARDA and Assistant Deputy Secretary, Office of the ASPR
US DHHS
 
DR CHRISTIAN MANDL
DR CHRISTIAN MANDL
Vice President, Global Head of Virology, Head Research, US
Novartis Vaccines and Diagnostics
 
DR LUDO LAUWERS
DR LUDO LAUWERS
Senior Vice President, Beerse R&D Site Manager
Johnson & Johnson Pharmaceuticals
 
G S REDDY
G S REDDY
Chief General Manager
Indian Immunologicals
 
ANDREW BAUM
ANDREW BAUM
Managing Director Equity Research
Morgan Stanley
 
DR THOMAS MUSTER
DR THOMAS MUSTER
Chief Executive Officer and Chief Scientific Officer
AVIR Green Hills Biotechnology
 
DR JOE SANTANGELO
DR JOE SANTANGELO
Chief Operating Officer
InViragen
 
DR OLE OLESEN
DR OLE OLESEN
Scientific Officer, Neglected Infectious Diseases, Infectious Diseases Unit
DG-Research European Commission
 
PIERRE MORGON
PIERRE MORGON
Vice President, Franchise and Global Marketing Operations
sanofi pasteur
 
DR MARIA ALLENDE
DR MARIA ALLENDE
Medical Director, Clinical Development, Vaccines
Baxter BioScience
 
JEAN-MARC RENARD
JEAN-MARC RENARD
Vice President, Corporate Development
sanofi pasteur
 
DR TAMAR BEN YEDIDIA
DR TAMAR BEN YEDIDIA
Chief Scientific Officer
BiondVax Pharmaceuticals
 
DR BENNEDIKT TIMMERMAN
DR BENNEDIKT TIMMERMAN
Chief Executive Officer
Genticel
 
DR ALAIN ROLLAND
DR ALAIN ROLLAND
Executive Vice President, Product Development
Vical
DR JEFFREY ALMOND
DR JEFFREY ALMOND
Vice President, Discovery and External Research and Development
sanofi pasteur
 
DR WOLFGANG WEIN
Executive Vice President, Global Business Unit Oncology
Merck Serono
 
 
JEFFREY HACKMAN
JEFFREY HACKMAN
Senior Vice President Commercial Operations
Intercell
 
DR JEAN LANG
DR JEAN LANG
Associated Vice President, Research and Development, Dengue Vaccine Program Head
sanofi pasteur
 
RAPHAEL WISNIEWSKI
RAPHAEL WISNIEWSKI
Investment Director, Life Sciences Group
Edmond de Rothschild Investment Partners
 
DR RAAFAT FAHIM
DR RAAFAT FAHIM
President and Chief Executive Officer
Nabi Pharmaceuticals
 
DR MARTIN BACHMANN
DR MARTIN BACHMANN
Chief Scientific Officer
Cytos Biotechnology
 
Not the right event for you?
 
Terrapinn runs a variety of events throughout the year. Please click on the following to see what else we can offer.
 
» visit the terrapinn website        
 
Contact LIVE
Location
World Vaccine Congress Lyon 2010

World health.

When: 04 Oct - 07 Oct
Where: Palais des Congrès de Lyon, Lyon
Category: Conference

2010 sponsors
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
Get connected
 

sponsorship opportunities
Sponsoring the World Vaccine Congress Lyon is a time and cost-effective opportunity to develop existing and new business.
 
Sponsorship packages offer your company thought-leadership positioning, branding, and the opportunity to set up face-to-face meetings with hundreds of decision makers from your target market in just 4 working days.
 
 
Target your market!
 
For details contact
Marc Rhys-Evans

Get sponsor pack